Publication Cover
Neurocase
Behavior, Cognition and Neuroscience
Volume 11, 2005 - Issue 1
147
Views
33
CrossRef citations to date
0
Altmetric
Original Articles

Biomarker profiles and their relation to clinical variables in mild cognitive impairment

, , , , , & show all
Pages 8-13 | Received 11 Mar 2004, Accepted 26 Apr 2004, Published online: 16 Aug 2006

References

  • Andreasen , N , Minthon , L , Vanmechelen , E , Vanderstichele , H , Davidsson , P , Winblad , B and Blennow , K. 1999 . Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer’s disease in patients with mild cognitive impairment . Neurosci Lett , 273 : 5 – 8 . [PUBMED] [INFOTRIEVE]
  • Andreasen , N , Vanmechelen , E , Vanderstichele , H , Davidsson , P and Blennow , K. 2003 . Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer’s disease in patients with mild cognitive impairment . Acta Neurol Scand , 179 : 47 – 51 . [CSA] [CROSSREF]
  • Arriagada , PV , Growdon , JH , Hedley-Whyte , ET and Hyman , BT. 1992 . Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease . Neurology , 42 ( 6 ) : 31 – 639 .
  • Blennow , K and Hampel , H. 2003 . CSF markers for incipient Alzheimer’s disease . Lancet Neurol , 2 : 605 – 613 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
  • Buerger , K , Teipel , SJ , Zinkowski , R , Blennow , K , Arai , H , Engel , R , Hofmann-Kiefer , K , McCulloch , C , Ptok , U , Heun , R , Andreasen , N , DeBernardis , J , Kerkman , D , Moeller , H , Davies , P and Hampel , H. 2002 . CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects . Neurology , 59 : 627 – 629 . [PUBMED] [INFOTRIEVE] [CSA]
  • De Leon , MJ , Segal , S , Tarshish , CY , DeSanti , S , Zinkowski , R , Mehta , PD , Convit , A , Caraos , C , Rusinek , H , Tsui , W , Saint Louis , LA , DeBernardis , J , Kerkman , D , Qadri , F , Gary , A , Lesbre , P , Wisniewski , T , Poirier , J and Davies , P. 2002 . Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment . Neurosci Lett , 333 : 183 – 186 . [PUBMED] [INFOTRIEVE] [CROSSREF]
  • Folstein , MF , Folstein , SE and McHugh , PR. 1975 . “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res , 12 ( 1 ) : 89 – 198 .
  • Giannakopoulos , P , Herrmann , FR , Bussière , T , Bouras , C , Kovari , E , Perl , DP , Morrison , JH , Gold , G and Hof , PR. 2003 . Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease . Neurology , 60 ( 1 ) : 495 – 1500 .
  • Grundman , M , Petersen , RC , Ferris , SH , Thomas , RG , Aisen , PS , Bennett , DA , Foster , NL , Jack , CR , Galasko , DR , Doody , R , Kaye , J , Sano , M , Mohs , R , Gauthier , S , Kim , HT , Jin , S , Schultz , AN , Schafer , K , Mulnard , R , van Dyck , CH , Mintzer , J , Zamrini , EY , Cahn-Weiner , D , Thal , LJ and Alzheimer’s Disease Cooperative Study . 2004 . Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials . Arch Neurol , 61 : 59 – 66 . [PUBMED] [INFOTRIEVE] [CROSSREF]
  • Guillozet , AL , Weintraub , S , Mash , DC and Mesulam , MM. 2003 . Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment . Arch Neurol , 60 : 729 – 736 . [PUBMED] [INFOTRIEVE] [CROSSREF]
  • Hampel , H , Teipel , SJ , Fuchsberger , T , Andreasen , N , Wiltfang , J , Otto , M , Shen , Y , Dodel , R , Du , Y , Farlow , M , Moller , HJ , Blennow , K and Buerger , K. Value of CSF beta-amyloid(1–42) and tau as predictors of Alzheimer’s disease in patients with mild cognitive impairment . Mol Psychiatry 2003 [Epub ahead of print]
  • Larrieu , S , Letenneur , L , Orgogozo , JM , Fabrigoule , C , Amieva , H , Le Carret , N , Barberger-Gateau , P and Dartigues , JF. 2002 . Incidence and outcome of mild cognitive impairment in a population-based prospective cohort . Neurology , 59 : 1594 – 1599 . [PUBMED] [INFOTRIEVE] [CSA]
  • Lindeboom , J , Schmand , B , Tulner , L , Walstra , G and Jonker , C. 2002 . Visual association test to detect early dementia of the Alzheimer type . J Neurol Neurosurg Psychiatry , 73 ( 1 ) : 26 – 133 .
  • Maruyama , M , Arai , H , Sugita , M , Tanji , H , Higuchi , M , Okamura , N , Matsui , T , Higuchi , S , Matsushita , S , Yoshida , H and Sasaki , H. 2001 . Cerebrospinal fluid amyloid beta(1–42) levels in the mild cognitive impairment stage of Alzheimer’s disease . Exp Neurol , 172 : 433 – 436 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
  • McKhann , G , Drachman , D , Folstein , M , Katzman , R , Price , D and Stadlan , EM. 1984 . Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease . Neurology , 34 ( 9 ) : 39 – 944 .
  • Morris , JC , Storandt , M , Miller , JP , McKeel , DW , Price , JL , Rubin , EH and Berg , L. 2001 . Mild cognitive impairment represents early-stage Alzheimer disease . Arch Neurol , 58 ( 3 ) : 97 – 405 . [CROSSREF]
  • Petersen , RC , Smith , GE , Waring , SC , Ivnik , RJ , Tangalos , EG and Kokmen , E. 1999 . Mild cognitive impairment . Arch Neurol , 56 ( 3 ) : 03 – 308 . [CROSSREF]
  • Petersen , RC , Stevens , JC , Ganguli , M , Tangalos , EG , Cummings , JL and DeKosky , ST. 2001 . Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology . Neurology , 56 : 1133 – 1142 . [PUBMED] [INFOTRIEVE] [CSA]
  • Reisberg , B , Ferris , S , De Leon , MJ and Crook , T. 1982 . The global deterioration scale for assessment of primary degenerative dementia . American Journal of Psychiatry , 139 : 1136 – 1139 . [PUBMED] [INFOTRIEVE]
  • Riemenschneider , M , Lautenschlager , N , Wagenpfeil , S , Diehl , J , Drzezga , A and Kurz , A. 2002 . Cerebrospinal fluid tau and β-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment . Arch Neurol , 59 : 1729 – 1734 . [PUBMED] [INFOTRIEVE] [CROSSREF]
  • Schoonenboom , SNM , Pijnenburg , YAL , Mulder , C , Rosso , SM , Van Elk , EJ , Van Kamp , GJ , Van Swieten , J and Scheltens , P. in press . Amyloid β 1–42 and phosphorylated tau in CSF as markers for early onset Alzheimer’s disease . Neurology ,
  • Schroder , J , Pantel , J , Ida , N , Essig , M , Hartmann , T , Knopp , MV , Schad , LR , Sandbrink , R , Sauer , H , Masters , CL and Beyreuther , K. 1997 . Cerebral changes and cerebrospinal fluid beta-amyloid in Alzheimer’s disease: a study with quantitative magnetic resonance imaging . Mol Psychiatry , 2 ( 50 ) : 5 – 507 . [CSA]
  • Skoog , I , Davidsson , P , Aevarsson , O , Vanderstichele , H , Vanmechelen , E and Blennow , K. 2003 . Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds . Dement Geriatr Cogn Disord , 15 : 169 – 176 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
  • Smith , GE , Bohac , DL , Waring , SC , Kokmen , E , Tangalos , EG , Ivnik , RJ and Petersen , RC. 1998 . Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer’s disease but not in healthy control subjects . Neurology , 50 : 355 – 362 . [PUBMED] [INFOTRIEVE] [CSA]
  • The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association . 1998 . Consensus report of the working group on: “Molecular and biochemical markers of Alzheimer’s Disease.” . Neurobiol Aging , 19 : 109 – 116 . [CSA] [CROSSREF]
  • Vandermeeren , M , Mercken , M , Vanmechelen , E , Six , J , van de Voorde , A , Martin , JJ and Cras , P. 1993 . Detection of tau proteins in normal and Alzheimer’s disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay . J Neurochem , 61 : 1828 – 1834 . [PUBMED] [INFOTRIEVE]
  • Vanderstichele , H , Van Kerschaver , E , Hesse , C , Davidsson , P , Buyse , MA , Andreasen , N , Minthon , L , Wallin , A , Blennow , K and Vanmechelen , E. 2000 . Standardization of measurement of beta amyloid (1–42) in cerebrospinal fluid and plasma . Amyloid , 7 : 245 – 258 . [PUBMED] [INFOTRIEVE] [CSA]
  • Visser , PJ , Verhey , FR , Ponds , RW , Kester , A and Jolles , J. 2000 . Distinction between preclinical Alzheimer’s disease and depression . J Am Geriatr Soc , 48 : 479 – 484 . [PUBMED] [INFOTRIEVE] [CSA]
  • Visser , PJ , Verhey , FR , Scheltens , P , Cruts , M , Ponds , RW , Van Broeckhoven , CL and Jolles , J. 2002 . Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects . J Neurol , 249 : 312 – 319 . [PUBMED] [INFOTRIEVE] [CROSSREF]
  • Wahlund , LO , Julin , P , Johansson , SE and Scheltens , P. 2000 . Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study . J Neurol Neurosurg Psychiatry , 69 : 630 – 635 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
  • Wahlund , LO and Blennow , K. 2003 . Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients . Neurosci Lett , 339 : 99 – 102 . [PUBMED] [INFOTRIEVE] [CROSSREF]
  • Zetterberg , H , Wahlund , LO and Blennow , K. 2003 . Cerebrospinal fluid markers for prediction of Alzheimer’s disease . Neurosci Lett , 352 : 67 – 69 . [PUBMED] [INFOTRIEVE] [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.